Publications (74) ENCARNACIÓN GONZÁLEZ RODRÍGUEZ publications

filter_list

2025

  1. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients

    Clinical and Translational Oncology, Vol. 27, Núm. 3, pp. 909-934

  2. Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention

    Cancers, Vol. 17, Núm. 4

  3. Evaluation of PTSO delivery approaches for gut microbiota modulation in colorectal cancer: A comparative study of microcapsules containing Allium derivatives

    Journal of Functional Foods, Vol. 128

  4. Gender and sex differences in colorectal cancer screening, diagnosis and treatment

    Clinical and Translational Oncology

  5. Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study

    Clinical and Translational Oncology, Vol. 27, Núm. 3, pp. 1176-1184

2024

  1. Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial

    ESMO Open, Vol. 9, Núm. 12

  2. Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study

    Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2217-2226

  3. Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review

    Clinical and Translational Oncology, Vol. 26, Núm. 4, pp. 851-863

  4. Retrospective registry of patients with locally advanced/metastatic HR+/HER2− breast cancer treated in clinical practice in Andalusia

    Clinical and Translational Oncology, Vol. 26, Núm. 12, pp. 3131-3141

  5. Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  6. SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)

    Clinical and Translational Oncology, Vol. 26, Núm. 11, pp. 2812-2825

  7. Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

    Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2640-2651

  8. Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain

    BMJ Quality and Safety

2023

  1. Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients

    Pharmaceutics, Vol. 15, Núm. 11

  2. Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review

    Cancers, Vol. 15, Núm. 6

  3. Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis

    NMR in Biomedicine, Vol. 36, Núm. 9

2022

  1. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 231-238

  2. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

    European Journal of Surgical Oncology, Vol. 48, Núm. 5, pp. 1123-1132

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Controversies in the treatment of RAS wild-type metastatic colorectal cancer

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 827-839